Research Updates

Back to project

Hereditary Hemorrhagic Telangiectasia (Osler-Weber-Rendu syndrome): update of November 16, 2026

What's new and why it matters

  1. A study is examining the surgical risks for patients with hereditary hemorrhagic telangiectasia who have heart infections and unusual bleeding issues. This research may help in understanding how to approach these complex cases (Item 1). Based on: 1
  2. Research is focused on better classifying genetic changes in the ACVRL1 gene, which is related to hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension. Improved classification could enhance patient management and care (Item 2). Based on: 2

Materials in this update

  1. Both-sided endocarditis in hereditary hemorrhagic telangiectasia: Weighing surgical risk against an unexplained bleeding phenotype.
    PubMed

    Nov 12, 2026

    This study looks at the surgical risks for patients with hereditary hemorrhagic telangiectasia (HHT) who have heart infections and unusual bleeding issues.

  2. Beyond the Black Box: Physics-Based and Conservation-Informed Evidence for ACVRL1 Variant Classification in Hereditary Hemorrhagic Telangiectasia and Pulmonary Arterial Hypertension.
    PubMed

    Oct 30, 2026

    This research aims to improve classifying genetic changes in the ACVRL1 gene linked to hereditary hemorrhagic telangiectasia (HHT) and pulmonary arterial hypertension.

All updates for Hereditary Hemorrhagic Telangiectasia (Osler-Weber-Rendu syndrome)
Email language